The market expected an early revenue step-up, but the quarter came in well short. Published estimates pointed to roughly $5.5 million of second-quarter revenue and negative $1.8 million of EBITDA; the filing delivered $1.9 million of revenue and $0.6 million of Adjusted EBITDA. Revenue therefore missed the operating forecast by about 65%, even though the company beat the EBITDA expectation through positive gross profit and cost adjustments.
| Metric | Q2 2026 actual | Q2 2025 | Published expectation |
|---|---|---|---|
| Revenue | $1.9m (Income Statement) | $0.4m (Income Statement) | ~$5.5m |
| Gross profit | $1.2m (Income Statement) | $(0.02)m (Income Statement) | — |
| Adjusted EBITDA | $0.6m (Adjusted EBITDA reconciliation) | $(1.7)m (Adjusted EBITDA reconciliation) | $(1.8)m |
| Net loss attributable to SharonAI | $(428.3)m (Income Statement) | $(2.6)m (Income Statement) | — |
The headline loss is mostly accounting noise, but the underlying cost base is still heavy. The $428.3 million attributable loss was driven primarily by a $400.4 million fair-value loss on convertible notes as the share price rose, plus a $6.1 million warrant-liability revaluation (Income Statement). Excluding those non-cash items, operations still lost $24.8 million, while selling, general and administrative expense rose to $8.7 million from $1.1 million (Income Statement). The positive $0.6 million Adjusted EBITDA is therefore encouraging, but it does not offset the large gap between current revenue and the scale implied by the company's contract pipeline.
The strategic contract story is substantial, but it remains mostly a future-delivery story. SharonAI reported $8.8 billion of total contract value, including a $1.32 billion five-year take-or-pay agreement, a $373 million five-year GPU deployment contract, a $4.9 billion NVIDIA collaboration, and added capacity taking the total to 212MW (Financial Highlights). These commitments provide unusually strong visibility if customers take delivery as planned, but the filing explicitly says revenue is expected to ramp materially from the third quarter of 2026 through 2027. In other words, the filing adds contractual backing to the growth narrative, not evidence that the ramp has arrived yet.
The balance sheet now funds the buildout, but at the cost of substantial financing and execution risk. Cash reached $1.86 billion versus $71.1 million at year-end, supported by $586.9 million of common-stock issuance, $1.07 billion of convertible-note proceeds, and $438.1 million from pre-funded warrants (Balance Sheet; Cash Flow statement). Against that, the company had $1.01 billion of convertible notes and spent or advanced roughly $326.3 million for property and equipment during the first half (Balance Sheet; Cash Flow statement). The net read is mixed: the capital and contracted demand are materially stronger than the tiny historical revenue base, but the quarter itself missed the expected ramp by a wide margin and leaves execution of the 2026–2027 deployment schedule as the central test.
Read the original 8-K on SEC EDGAR ↗